APA (7th ed.) Citation

F, P., Z, K., & C, S. (2025). Comparative analysis of the addition of empagliflozin versus doubling the furosemide dose in decompensated heart failure. Cardiovascular drugs and therapy, 39(5), 1033. https://doi.org/10.1007/s10557-024-07593-x

Chicago Style (17th ed.) Citation

F, Polat, Kaya Z, and Süleymanoğlu C. "Comparative Analysis of the Addition of Empagliflozin Versus Doubling the Furosemide Dose in Decompensated Heart Failure." Cardiovascular Drugs and Therapy 39, no. 5 (2025): 1033. https://doi.org/10.1007/s10557-024-07593-x.

MLA (9th ed.) Citation

F, Polat, et al. "Comparative Analysis of the Addition of Empagliflozin Versus Doubling the Furosemide Dose in Decompensated Heart Failure." Cardiovascular Drugs and Therapy, vol. 39, no. 5, 2025, p. 1033, https://doi.org/10.1007/s10557-024-07593-x.